Navigation Links
Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pennsylvania
Date:12/12/2007

aking medications for chronic conditions like

diabetes or asthma are significantly more likely to inquire about

generics. In fact, 54 percent of members with chronic conditions

indicated they were more likely to ask about generic drugs compared to

members needing prescriptions less often (54 percent versus 32 percent).

Financial Reasons to Switch

When the concept of financial savings for generics was raised in the

survey, one in four members said that they are motivated to switch to

generics when there is a cost savings to them of $20 or greater, between

the generic and the brand name prescription. Those with chronic conditions

also answered the most positively about No Pay Copay saving them money. A

sizeable 56 percent said No Pay Copay saved them from cutting back on

other important expenses. A whopping 94 percent said they know that

generics save consumers a significant amount of money overall.

Generic Drugs Benefit Everyone

Eighty-six percent of those surveyed said they feel good that IBC is

proactively trying to keep health care costs under control with member

incentive programs like No Pay Copay.

After No Pay Copay ends, members will be able to continue saving money by choosing generic drugs, because they cost significantly less than brand name drugs. IBC's prescription drug plans always offer the lowest copay amount for generics.

Independence Blue Cross Encourages Everyone to Be Smart Health Care Consumers

IBC encourages every consumer to ask his or her doctor or pharmacist if there is a suitable generic alternative for any brand name drug prescribed. Even if a drug is not yet manufactured in generic form, there is often a so- called generic therapeutic alternative available that treats the same condition with a different chemical, and can offer the same results.

"A generic therapeutic alternative requires a new prescription," sa
'/>"/>

SOURCE Independence Blue Cross
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
6. Generic prostate drug helps find high-risk cancers early
7. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
8. Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
9. FDA Announces Initiative to Bolster Generic Drug Program
10. FDA Struggles to Keep Pace With Requests for Generics
11. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Are angry women more like men? 2
...r the first time, a new study has looked into how ...derstand and retell a script-based story. , When...ing to a restaurant, we remember the kinds of acti...are listening to a story that takes place at a res...
...sudden loss of T cells -- white blood cells crucia...he onset of AIDS, according to a study published i...ology by a team of researchers at Tulane National ... current thinking regarding AIDS, namely that a su...
...NGTON, Sept. 21 Business Roundtable and,the Ameri...h the,Roundtable,s Partnership for Disaster Respon...the business community to contribute its vast,reso...ement is timed with National Preparedness Month, a...
...ned National Security Facility to Offer EHR-Enhanc...tration/Billing for 8,500 Employees ...ghlights Growing Trend of Computer-Enhanced Onsite...linical software and,information solutions that ph...
...IEGO, Sept. 21 ChemDiv, Inc. (San Diego) announce...tute (CDRI, Moscow) is,undertaking a partnership w...the Russian Academy of Medical Sciences, the US De...state cancer,(PRC). The partnership will operate u...
...WOOD, Colo., Sept. 21 Baxa Corporation, a leading...elivery in hospital,pharmacies, announces the addi.... These agreements -- with Magallan Pharma Trading... South,America and the Caribbean. "Global markets...
Other Medicine News:Health News:Progression of SIV infection in monkeys raises 2Health News:Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nation's Preparedness for Disasters 2Health News:Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nation's Preparedness for Disasters 3Health News:Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nation's Preparedness for Disasters 4Health News:Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center 2Health News:Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center 3Health News:Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center 4Health News:Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership 2Health News:Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership 3Health News:Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 2
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 1Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 2Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 3Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 4Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 6Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 7Stent Studies Tied to Rapid Changes in Use 52992 1Stent Studies Tied to Rapid Changes in Use 52992 2DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 1DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 2
...27 A doctor who is,internationally recognized for...cally for research on DHA, an omega-3 fatty acid, ...d for outstanding achievement in the field,of mate...as among the first to report that infants,receivin...oic acid) levels,than formula-fed infants and the ...
...ur Years of Treatment Presented at ICAAC/IDSA,2008...ough,Corporation (NYSE: SGP ) today reported a da...tional CCR5 receptor antagonist, demonstrated,sust...nts and was well,tolerated through up to four year... patients. Vicriviroc was administered once-daily ...
Other Medicine Technology:March of Dimes Honors Dr. Susan Carlson for Outstanding Work In Maternal-Fetal Nutrition 2Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 2Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 3Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 4Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 5Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients 6
DNA Engine Thermal Cycler Chassis, w/96-well block & motorized lid
DNA Engine Thermal Cycler Chassis
MBS Satellite Thermal Cycler 0.5ml
MBS Satellite Thermal Cycler 0.2ml
Medicine Products: